2
Registered trials
1
Recruiting
2
Unique sponsors
11
Unique IMPs
0
Commercial trials
Drug classes (ATC)
B
Haematology (ATC B)
2
N
Neurology/Psychiatry (ATC N)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
5 substances
Heparin / LMWH
4 substances
Analgesic / antipyretic
1 substance
Supportive / diluent
1 substance
Phase IV:
2
Phase IV
2 trials-
EndedCentre Hospitalier Universitaire De Nantes AcademicKETAMINE HYDROCHLORIDE; NEFOPAM HYDROCHLORIDE; PARACETAMOL; REMIFENTANIL HYDROCHLORIDE; SODIUM CHLORIDE; TRAMADOL HYDROCHLORIDE
-
RecruitingRigshospitalet AcademicDALTEPARIN SODIUM; ENOXAPARIN SODIUM; HUMAN PLASMA PROTEINS WITH NOT LESS THAN 96% ALBUMIN; NADROPARIN CALCIUM; TINZAPARIN SODIUM
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Centre Hospitalier Universitaire De Nantes | Academic | 1 | Phase IV | 0 |
| Rigshospitalet | Academic | 1 | Phase IV | 1 |
New trials by year
2025
2